ANIP - ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21 revenue of $64.48M misses by $0.55M
ANI Pharmaceuticals press release (NASDAQ:ANIP): Q1 Non-GAAP EPS of -$0.12 misses by $0.21. Revenue of $64.48M (+18.3% Y/Y) misses by $0.55M. Provides Purified Cortrophin® Gel 2022 Net Revenue guidance of $35 million to $40 million, Total Company Net Revenue guidance of $295 million to $315 million and adjusted non-GAAP EBITDA guidance to $54 million to $60 million.
For further details see:
ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55M